D
Dermatologie Maldegem | Maldegem, Belgium
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
AMG 451
guselkumab
Secukinumab
Bimekizumab
Ixekizumab
secukinumab
ixekizumab
Risankizumab
Guselkumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 7 total trials
Locations recently updated
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Enrolling
Atopic Dermatitis
Drug: Rocatinlimab
Other: Placebo
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...
Active, not recruiting
Atopic Dermatitis
Drug: Rocatinlimab
Drug: Placebo
Trial sponsors
G
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems